JLE

Hépato-Gastro & Oncologie Digestive

MENU

Management of anemia and neutropenia in digestive oncology: Let's move from good intentions to good clinical practices! Volume 26, supplement 1, Octobre 2019

  • [1] Aapro M., Beguin Y., Bokemeyer C. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29:iv96-110. Suppl. 4
  • [2] Aapro M.S., Bohlius J., Cameron D.A. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011;47:8-32.
  • [3] Klastersky J., de Naurois J., Rolston K. Management of febrile neutropaenia : ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27:v111-v118. Suppl. 5
  • [4] Taplitz R.A., Kennedy E.B., Flowers C.R. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1443-1453. 14
  • [5] Freifeld A.G., Bow E.J., Sepkowitz K.A. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93. 4
  • [6] Averbuch D., Orasch C., Cordonnier C. ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98:1826-1835. 12